IPSC - היקף יתרות המזומנים של החברה centurytx.com

Century Therapeutics develops allogeneic therapies based on induced pluripotent stem cells, leveraging a proprietary patented platform. The company is advancing universal cancer treatments designed for mass clinical application. The cash level on GURU.Markets reflects liquidity dynamics, where the value 0.12 indicates the current amount. R&D has currently peaked in the development of innovative NK and T-cells.
פילוחי מדדים פיננסיים ומדדי שוק עבור Century Therapeutics (IPSC)

The development of Century Therapeutics (IPSC) is critically dependent on the success of its R&D projects, which makes capital control a priority in the absence of stable commercial revenue. By analyzing changes in cash and cash equivalents, an investor assesses the volume of liquid reserves and the burn rate, which determines the survival horizon of this venture asset before a new funding round is required or a default occurs.